EPiC is delighted to announce that our nomination for Liz Allanson, Founder and co‑owner of EPiC, has been shortlisted for the Outstanding Contribution Award at the Making Pharmaceuticals, Distributing Pharmaceuticals, and Making Nutraceuticals 2026 Excellence Awards.
We are thrilled that Liz has been selected as one of just three finalists in the category, recognising the significant and lasting impact she has made across the pharmaceutical and healthcare sectors.
Full details of all award shortlists are available at: https://www.makingpharma.com/awards-shortlist/
A Career Defined by Commitment to Quality and Patient Safety
Liz’s remarkable career spans more than three decades and showcases unwavering dedication to regulatory excellence, patient safety, and the advancement of pharmaceutical quality. Her leadership, integrity, and passion have influenced professionals and organisations across the NHS, MHRA, and global industry.
NHS Pharmaceutical Quality Assurance
Liz began her career with 12 years working in NHS Pharmaceutical Quality Assurance, where she strengthened GMP compliance, enhanced the safety of manufactured and prepared medicines, contributed to national quality guidelines, and mentored pharmacists and technicians to uphold the highest standards.
MHRA Regulatory GMP Inspectorate
Liz dedicated 19 years to the MHRA as a Regulatory GMP Inspector, ultimately managing the UK’s GMP inspection programme. Her work shaped EU and PIC/S regulatory frameworks, informed key legislative updates, and supported improvements in quality systems across both industry and healthcare settings. She conducted inspections worldwide and provided essential guidance that raised GMP standards internationally.
Consultancy, Mentorship, and Industry Leadership
Alongside her regulatory leadership, Liz has spent over 22 years in consultancy. She has mentored countless Qualified Persons, delivered extensive audits, co‑created the world’s first GMP Lead Auditor accreditation, and co‑founded EPiC, a consultancy built on expertise, ethics, passion, and patient‑centred values. Her influence continues to shape best practice across the sector.
Why We Feel Liz Should Win The Outstanding Contribution Award
Liz exemplifies exceptional leadership, dedication, and influence. Her lifelong contribution has:
- strengthened regulatory practice and understanding
- advanced product quality and patient safety
- inspired and developed professionals across the sector
- influenced guidance, legislation, and industry expectations
- shaped high‑quality, patient‑focused consultancy through EPiC
Her impact is felt not only in the UK but internationally, through her guidance, mentorship, and commitment to doing what is right for patients and the profession.
Looking Ahead to the Awards and Conference
EPiC’s directors are very much looking forward to attending the Awards Dinner on the 21st of April 2026, where the winner of the Outstanding Contribution Award will be announced.
We will also be attending and exhibiting at the Making Pharmaceuticals, Distributing Pharmaceuticals, and Making Nutraceuticals Conference at the Coventry Building Society Confernce at the Coventry Building Society Arena on 21–22 April